Prognostic performance of soluble urokinase plasminogen activator receptor for heart failure or mortality in Western and Asian patients with acute breathlessness

The performance of circulating soluble urokinase plasminogen activator receptor (suPAR) for predicting the composite endpoint of subsequent heart failure (HF) hospitalisation and/or death at 1  year was assessed in (i) patients with undifferentiated breathlessness, and generalisability was compared in (ii) disparate Western versus Asian sub-cohorts, and in (iii) the sub-cohort adjudicated with HF.

Source: International Journal of Cardiology - April 19, 2024 Category: Cardiology Authors: Janice Chew-Harris, Chris Frampton, Charlotte Greer, Sarah Appleby, John W. Pickering, Win Sen Kuan, Irwani Ibrahim, Siew Pang Chan, Zisheng Li, Oi Wah Liew, Philip D. Adamson, Richard Troughton, Li Ling Tan, Weiqin Lin, Shirley Beng Suat Ooi, A. Mark Ric Source Type: research